Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Audiometry, Pure-Tone × Clear all

Phase

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Presbycusis 1 Hearing Loss 1

Interventions

Cyclophosphamide 2741 Cisplatin 2713 Carboplatin 2513 Radiotherapy 2326 Paclitaxel 2302 Gemcitabine 2174 pembrolizumab 1998 Docetaxel 1886 Bevacizumab 1826 Fluorouracil 1579 Capecitabine 1556 Oxaliplatin 1468 Dexamethasone 1366 Nivolumab 1292 Doxorubicin 1280 Rituximab 1262 Etoposide 1158 Magnetic Resonance Spectroscopy 1086 Irinotecan 1065 Leucovorin 1050 Cytarabine 987 fludarabine 912 Drug Therapy 912 Pemetrexed 898 Vincristine 816 Lenalidomide 800 Prednisone 798 Cetuximab 787 Filgrastim 783 Specimen Handling 781

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06894927 2025-05-30

HSA50+

University Hospital Hradec Kralove

Phase NA Enrolling by invitation

Presbycusis, Hearing Loss

Data powered by HemOnc (CC BY 4.0) Colophon ⚡